Alexion Pharmaceuticals, Inc. · 1 day ago
Discovery Biology Therapeutic Optimization Intern (PhD)
New Haven, Connecticut, United States of America
Internship
Onsite
Intern
$48/hr - $48/hr
2+ years exp
Start in 2026 SummerAlexion Pharmaceuticals, Inc. is seeking PhD students for a 10-week internship role at their New Haven, CT site. The role focuses on developing immunogenicity assays for T cell activation and benchmarking immunogenicity metrics.
BiotechnologyHealth CareMedicalTherapeutics
No H1B
Responsibilities
Develop immunogenicity Assays for T cell activation
Benchmark immunogenicity metrics of in vitro, in silico, and clinical data
Develop a risk assessment decision tree for discovery biologics for immunogenicity risk assessment
Qualification
Required
PhD students studying immunology, cell biology, biophysics, biochemistry, molecular biology, or a related discipline
Candidates must have an expected graduation date after August 2026
At least 2 years of experience in a research lab is required
Experience with immunofluorescence assays is required
The ability to keep high levels of housekeeping, safety, and environmental standards in the laboratory is required
US Work Authorization is required at time of application
Ability to report onsite to our New Haven, CT 4-5 days per week
Preferred
Experience in mammalian tissue culture
Completed coursework in immunology
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Frederic Chereau
SVP, Strategy and Business Development
Imran Shakur
Director, IRT and Technology Lead
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase